MX2007005317A - Modalidades de formacion de imagen para seleccionar agentes terapeuticos para la enfermedad de alzheimer. - Google Patents
Modalidades de formacion de imagen para seleccionar agentes terapeuticos para la enfermedad de alzheimer.Info
- Publication number
- MX2007005317A MX2007005317A MX2007005317A MX2007005317A MX2007005317A MX 2007005317 A MX2007005317 A MX 2007005317A MX 2007005317 A MX2007005317 A MX 2007005317A MX 2007005317 A MX2007005317 A MX 2007005317A MX 2007005317 A MX2007005317 A MX 2007005317A
- Authority
- MX
- Mexico
- Prior art keywords
- imaging modalities
- disease therapeutics
- screening alzheimer
- screening
- alzheimer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
- A01K67/027—New breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0312—Animal model for Alzheimer's disease
Abstract
El uso de modelos animales de trastornos neurodegenerativos para el establecimiento de indices de diagnostico y terapeuticos preclinicos, y para los metodos de evaluacion, para identificar las terapias preclinicas efectivas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62516204P | 2004-11-05 | 2004-11-05 | |
PCT/US2005/039865 WO2006052691A2 (en) | 2004-11-05 | 2005-11-03 | Pet and magnetic resonance for screening alzheimer's disease therapeutics |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007005317A true MX2007005317A (es) | 2007-06-11 |
Family
ID=36129750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007005317A MX2007005317A (es) | 2004-11-05 | 2005-11-03 | Modalidades de formacion de imagen para seleccionar agentes terapeuticos para la enfermedad de alzheimer. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060117397A1 (es) |
EP (1) | EP1807119A2 (es) |
JP (1) | JP2008519282A (es) |
CN (1) | CN101072591A (es) |
AU (1) | AU2005304931A1 (es) |
BR (1) | BRPI0517672A (es) |
CA (1) | CA2586220A1 (es) |
MX (1) | MX2007005317A (es) |
WO (1) | WO2006052691A2 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9017724B2 (en) | 2004-02-24 | 2015-04-28 | The General Hospital Corporation | Catalytic radiofluorination |
US8257680B1 (en) | 2004-02-24 | 2012-09-04 | The General Hospital Corporation | Catalytic radiofluorination |
WO2006124956A1 (en) * | 2005-05-17 | 2006-11-23 | Satori Pharmaceuticals, Inc. | Compounds useful for treating neurodegenerative disorders |
EP1955190B1 (en) * | 2005-11-10 | 2018-08-29 | In Silico Biosciences, Inc. | Method and apparatus for computer modeling the human brain for predicting drug effects |
JP5153114B2 (ja) * | 2006-10-12 | 2013-02-27 | 知宏 千葉 | 新規のアルツハイマー病検出方法 |
JP5319121B2 (ja) * | 2007-01-30 | 2013-10-16 | 株式会社東芝 | 診療支援システム及び診療支援装置 |
CA2680762A1 (en) * | 2007-03-12 | 2008-09-25 | National Institute Of Radiological Sciences | Pet visualization of amyloid-associated neuroinflammation in the brain |
EP2155259A2 (en) * | 2007-05-10 | 2010-02-24 | The Trustees of Columbia University in the City of New York | Methods for diagnosing diseases and evaluating treatments therefor using pet |
WO2008154415A1 (en) * | 2007-06-08 | 2008-12-18 | New York University | Stage specific prognostic in vivo markers of brain aging and dementia |
CL2007002908A1 (es) | 2007-10-09 | 2008-05-30 | Univ Concepcion | Procedimiento electroquimico in vitro para evaluar capacidad neurotoxica de estructuras, principios activos y/o compuestos de interes en celulas vivas y que comprende medir y cuantificar los parametros electricos en membranas expuestas a dichos agreg |
EP2268647B1 (en) | 2008-03-21 | 2017-01-25 | The General Hospital Corporation | Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders |
ES2685464T3 (es) * | 2008-04-04 | 2018-10-09 | The Regents Of The University Of California | Nanopartículas magnéticas funcionalizadas y métodos de uso de las mismas |
US8593141B1 (en) | 2009-11-24 | 2013-11-26 | Hypres, Inc. | Magnetic resonance system and method employing a digital squid |
MX2012011924A (es) * | 2010-04-13 | 2013-03-05 | Baxter Healthcare Sa | Uso de tasa de aumento de tamaño ventricular en el tratamiento intravenoso con inmunoglobulina de la enfermedad de alzheimer. |
US8970217B1 (en) | 2010-04-14 | 2015-03-03 | Hypres, Inc. | System and method for noise reduction in magnetic resonance imaging |
DE102012209059B4 (de) | 2012-05-30 | 2024-05-02 | Siemens Healthineers Ag | Verfahren und Vorrichtung zur Bestimmung einer zeitlichen Änderung eines Biomarkers in einem Untersuchungsgebiet |
US10203388B2 (en) | 2016-01-04 | 2019-02-12 | Toshiba Medical Systems Corporation | Magnetic resonance imaging apparatus and magnetic resonance imaging method |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69233774D1 (de) * | 1991-01-21 | 2009-12-10 | Elan Pharm Inc | Prüfung und Modell für Alzheimers-Krankheit |
ATE198622T1 (de) * | 1993-10-27 | 2001-01-15 | Elan Pharm Inc | Transgene tiere, die app allele mit der schwedischen mutation beherbergen |
JPH07132033A (ja) * | 1993-11-12 | 1995-05-23 | Hoechst Japan Ltd | アルツハイマー病モデルトランスジェニック動物 |
US5877399A (en) * | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
US6717031B2 (en) * | 1995-06-07 | 2004-04-06 | Kate Dora Games | Method for selecting a transgenic mouse model of alzheimer's disease |
US5894078A (en) * | 1996-02-26 | 1999-04-13 | Advanced Bioconcept, Inc. | Transgenic mouse expressing C-100 app |
US5849999A (en) * | 1996-10-16 | 1998-12-15 | The Mclean Hospital Corporation | Transgenic non-human mice expressing Flag-APP-C100 protein develop alzheimer's disease brain morphology and behavior |
US5898094A (en) * | 1996-10-21 | 1999-04-27 | University Of South Florida | Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes |
US6284944B1 (en) * | 1997-08-29 | 2001-09-04 | Cephalon, Inc, | Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspring |
US6175057B1 (en) * | 1997-10-08 | 2001-01-16 | The Regents Of The University Of California | Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy |
US5846197A (en) * | 1998-03-16 | 1998-12-08 | Beth Israel Deaconess Medical Center | Compensating for magnetization transfer effects in multislice and three-dimensional MRI blood flow mapping studies |
US6664443B1 (en) * | 1998-05-01 | 2003-12-16 | Mayo Foundation For Medical Education And Research | Pathogenic Tau mutations in transgenic mice |
EP1105163A4 (en) * | 1998-08-20 | 2003-05-02 | Univ California | METHOD FOR MARKING AMYLOID PLAQUES AND NEUROFIBRILLIC GIFTS |
US6374130B1 (en) * | 1999-04-06 | 2002-04-16 | Eric M. Reiman | Methods for tracking the progression of Alzheimer's disease identifying treatment using transgenic mice |
US7371920B2 (en) * | 2000-06-20 | 2008-05-13 | The Governing Council Of The University Of Toronto | Transgenic mouse model of neurodegenerative disorders |
US6593516B1 (en) * | 2002-10-03 | 2003-07-15 | Rico Corp. | Holder for a musical instrument reed |
US20050102708A1 (en) * | 2003-03-12 | 2005-05-12 | Laurent Lecanu | Animal model simulating neurologic disease |
-
2005
- 2005-11-03 BR BRPI0517672-7A patent/BRPI0517672A/pt not_active IP Right Cessation
- 2005-11-03 WO PCT/US2005/039865 patent/WO2006052691A2/en active Application Filing
- 2005-11-03 MX MX2007005317A patent/MX2007005317A/es not_active Application Discontinuation
- 2005-11-03 CA CA002586220A patent/CA2586220A1/en not_active Abandoned
- 2005-11-03 EP EP05821147A patent/EP1807119A2/en not_active Withdrawn
- 2005-11-03 CN CNA2005800416995A patent/CN101072591A/zh active Pending
- 2005-11-03 AU AU2005304931A patent/AU2005304931A1/en not_active Abandoned
- 2005-11-03 JP JP2007540047A patent/JP2008519282A/ja active Pending
- 2005-11-04 US US11/266,230 patent/US20060117397A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0517672A (pt) | 2008-10-14 |
CN101072591A (zh) | 2007-11-14 |
WO2006052691A2 (en) | 2006-05-18 |
CA2586220A1 (en) | 2006-05-18 |
EP1807119A2 (en) | 2007-07-18 |
US20060117397A1 (en) | 2006-06-01 |
JP2008519282A (ja) | 2008-06-05 |
AU2005304931A1 (en) | 2006-05-18 |
WO2006052691A3 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007005317A (es) | Modalidades de formacion de imagen para seleccionar agentes terapeuticos para la enfermedad de alzheimer. | |
WO2011045415A3 (en) | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases | |
WO2008048410A3 (en) | Diagnostic methods and genetic markers for alzheimer disease | |
EA016193B9 (ru) | Антитела, направленные против бета-амилоидного пептида, и способы их использования | |
Kukolja et al. | Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus | |
MY164376A (en) | Phosphospecific antibodies recognizing tau | |
WO2006102370A3 (en) | Functional brain mri mapping as a marker in cns diseases and disorders | |
EA201590833A1 (ru) | Антитела для лечения и профилактики болезни альцгеймера и их применение | |
MX354662B (es) | Anticuerpos fosfoespecificos que reconocen la tau. | |
IL208926A0 (en) | Use of epothelone d in treating tau-associated diseases including alzheimer's disease | |
NO20090156L (no) | Humanisert antistoff | |
MY171300A (en) | Pharmaceutical composition | |
EA200700427A1 (ru) | Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний | |
EP1951892A4 (en) | ANTIBODY TREATMENT OF MORBUS ALZHEIMER AND RELATED DISEASES | |
WO2007149293A3 (en) | Transgenic flies expressing tau and amyloid precursor fragment | |
EP2001503A4 (en) | DIAGNOSIS AND TREATMENT OF MORBUS ALZHEIMER | |
Hagiwara et al. | Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors | |
WO2018060766A3 (en) | Genetic susceptibility diagnosis and treatment of mental disorders | |
WO2006091964A8 (en) | Regulators of protein misfolding and aggregation and methods of using the same | |
PH12012501882B1 (en) | Humanized antibody against amyloid beta | |
GB0701177D0 (en) | Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders | |
EP1769089A4 (en) | METHODS AND COMPOSITIONS FOR PRE-SYMPTOMATIC OR POST-SYMPTOMATIC DIAGNOSIS OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS | |
Kim | The effects of home visit healthcare using a complex program on community-dwelling frail elders' strength, frailty, and depression | |
EP2147117A4 (en) | METHOD FOR DIAGNOSIS OF MORBUS ALZHEIMER AND MARKERS IDENTIFIED BY SET ASSOCIATION | |
Olympics | Healthy athletes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |